methylprednisolone has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.59) | 18.7374 |
1990's | 2 (3.17) | 18.2507 |
2000's | 14 (22.22) | 29.6817 |
2010's | 38 (60.32) | 24.3611 |
2020's | 8 (12.70) | 2.80 |
Authors | Studies |
---|---|
Agrawal, R; Chee, WK; Ho, SL; Koong, LR; Ng, XL; Toh, ZH | 1 |
Goto, H; Hori, J; Kaneko, Y; Miyata, K; Mizuki, N; Mochizuki, M; Nakano, S; Nao-I, N; Nitta, F; Ohguro, N; Ono, T; Sakai, T; Takase, H; Tomita, M | 1 |
Fushitsu, R; Ishibazawa, A; Kinouchi, R; Murono, M | 1 |
Li, H; Liu, J; Sun, S; Zhang, Y; Zhao, G; Zhao, X | 1 |
Awano, H; Katsuyama, A; Kusuhara, S; Matsumiya, W; Nagase, H; Nakamura, M | 1 |
Barun, B; Dapic Ivancic, B; Petelin Gadze, Z; Radic, B; Vukojevic, N | 1 |
Do, DV; Li, AS; Tang, PH | 1 |
Fan, X; Han, H; Tian, M; Zhang, Q | 1 |
Agarwal, A; Aggarwal, K; Bansal, R; Freund, KB; Gupta, V; Katoch, D; Kumar, A; Sharma, D | 1 |
Cho, IH; Lee, EK; Park, UC; Yu, HG | 1 |
Agrawal, R; Bhende, M; Biswas, J; Jaisankar, D; Khandelwal, N; Raman, R; Sharma, HR; Sridharan, S | 1 |
Iqbal, M; Khan, F; Raza, SS; Zahid, S | 1 |
Fusumae, T; Inoda, S; Kamiya, K; Kawashima, H; Komine, M; Maekawa, T; Murata, S; Ohtsuki, M; Takahashi, R | 1 |
Fukuchi, T; Ishii, A; Kakehashi, A; Kawamura, A; Sugawara, H; Toyoda, F; Watanabe, T; Yamashita, T; Yoshida, K; Yoshino, N | 1 |
Chen, CL; Chen, JT; Chen, YH; Huang, KH; Lee, LC; Lin, LF; Lu, DW; Tai, MC; Weng, TH | 1 |
Keino, H; Nakayama, M; Okada, AA; Watanabe, T | 1 |
Gilhotra, J; Hissaria, P; Le, TA; Simon, S | 1 |
Al Banna, M; Ghannam, M; Reeder, S; Robertson, J; Stutz, A | 1 |
Amano, H; Hattori, T; Ishikawa, O; Kamiyama, Y; Kato, M; Motegi, S; Shimizu, A | 1 |
Hangai, M; Hosoda, Y; Morooka, S; Nishijima, K; Uji, A; Yoshimura, N | 1 |
Bascherini, V; Cantarini, L; Caso, F; Costa, L; Franceschini, R; Latronico, E; Rigante, D; Vitale, A | 1 |
Costa, RA; da Silva, FT; Hirata, CE; Kalil, J; Marin, ML; Rodrigues, H; Sakata, VM; Yamamoto, JH | 1 |
Ishii, K; Kaburaki, T; Kurita, N; Takada, S; Tanaka, R | 1 |
Accorinti, M; Amorelli, GM; Gilardi, M; Nardella, C; Pesci, FR | 1 |
Fujiwara, T; Hashizume, K; Imamura, Y; Ishida, M; Kurosaka, D; Machida, S | 1 |
Hashimoto, Y; Hirooka, K; Ishida, S; Iwata, D; Mizuuchi, K; Namba, K; Saito, W | 2 |
Kim, M | 1 |
Abu El-Asrar, AM; Al Mudhaiyan, T; Al Najashi, AA; Al-Muammar, A; Hariz, R; Hemachandran, S; Mousa, A | 1 |
Chew, SK; Levy, J; Lim, LL; Rogers, S | 1 |
Abdallah, SF; da Silva, FT; Hirata, CE; Lavezzo, MM; Machado, CG; Morita, C; Oyamada, MK; Rodriguez, EE; Sakata, VM; Yamamoto, JH | 1 |
Abu El-Asrar, AM; Al-Muammar, A; Dosari, M; Gikandi, PW; Hemachandran, S | 1 |
Gupta, A; Gupta, P; Gupta, V; Sharma, A | 1 |
Baizri, H; Ghafir, D; Mounach, J; Qaçif, H; Sekkach, Y | 1 |
Bouchenaki, N; Herbort, CP; Horie, S; Kawaguchi, T; Mochizuki, M; Ohno-Matsui, K | 1 |
Hashimoto, T; Ohta, K; Takizawa, H; Yukimura, K | 1 |
Teoh, SC; Tien, MC | 1 |
Hangai, M; Ishihara, K; Kita, M; Yoshimura, N | 1 |
Fujiwara, T; Hamabata, K; Hashizume, K; Ishikawa, Y; Kurosaka, D; Machida, S | 1 |
Bouraoui, R; Chebil, A; El Matri, L; Kort, F; Youssef, NB | 1 |
Keane, PA; Rao, NA; Sadda, SR | 1 |
Kim, JY; Nam, KY; Park, HS | 1 |
Al Dousary, S | 1 |
Fujiwara, T; Iida, T; Maruko, I; Oyamada, H; Sekiryu, T; Spaide, RF; Sugano, Y | 1 |
Igarashi, A; Kamiya, K; Otsuki, T; Shimizu, K | 1 |
Gao, X; Li, X | 1 |
Nakamura, M; Nishijima, K; Yamamoto, M; Yoshimura, N | 1 |
Berman, DC; Nielsen, H; Smit, J | 1 |
Gomi, F; Ikuno, Y; Nakai, K; Nishida, K; Nouchi, T; Ohguro, N; Yasuno, Y | 1 |
Amarasinghe, B; de Silva, HJ; Nawasiwatte, BM; Premaratna, R | 1 |
Abu El-Asrar, AM; Al-Mezaine, HS; Al-Muammar, AM; Hemachandran, S; Kangave, D | 1 |
Imoto, Y; Nakagawa, Y; Ohguro, N; Tano, Y; Yamamoto, S; Yamanaka, E | 1 |
Kawaguchi, T; Mochizuki, M; Sugita, S; Yokota, M | 1 |
Accorinti, M; Bodaghi, B; Chee, SP; Fardeau, C; Goto, H; Holland, GN; Kawashima, H; Kojima, E; Lehoang, P; Lemaitre, C; Okada, AA; Pivetti-Pezzi, P; Rao, NA; Read, RW; Secchi, A; See, RF; Tabbara, KF; Usui, M; Yu, F | 1 |
Kato, T; Kato, Y; Kurimura, M; Tajima, K; Yahata, Y | 1 |
Kira, J | 1 |
Kishi, S; Otani, T; Yamaguchi, Y | 1 |
Bennett, FM | 1 |
Bradley, ST; Chen, CJ; Evans, OB; Gruich, MJ; Storey, JM | 1 |
Messmer Uccelli, M; Solaro, C | 1 |
Kamondi, A; Papp, A; Seres, A; Szegedi, A; Szirmai, I | 1 |
Bouchenaki, N; Herbort, CP | 1 |
Matsuda, H; Ohno, S; Sasamoto, Y | 1 |
1 review(s) available for methylprednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
Positron emission tomography/computed tomography scan of Vogt-Koyanagi-Harada syndrome with associated autoimmune thyroid disease: A case report and literature review.
Topics: Female; Fluorodeoxyglucose F18; Glucocorticoids; Headache; Humans; Methylprednisolone; Middle Aged; Positron Emission Tomography Computed Tomography; Thyroiditis, Autoimmune; Uveomeningoencephalitic Syndrome; Vision Disorders | 2018 |
2 trial(s) available for methylprednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
Comparison of combination therapy of prednisolone and cyclosporine with corticosteroid pulse therapy in Vogt-Koyanagi-Harada disease.
Topics: Cyclosporine; Humans; Methylprednisolone; Prospective Studies; Uveomeningoencephalitic Syndrome | 2022 |
Evaluation of pulse corticosteroid therapy for vogt-koyanagi-harada disease assessed by optical coherence tomography.
Topics: Acute Disease; Diagnostic Techniques, Ophthalmological; Drug Evaluation; Glucocorticoids; Humans; Infusions, Intravenous; Interferometry; Light; Methylprednisolone; Pulse Therapy, Drug; Retinal Detachment; Tomography; Uveomeningoencephalitic Syndrome | 2002 |
60 other study(ies) available for methylprednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
Vogt-Koyanagi-Harada Disease Associated with COVID-19 mRNA Vaccine.
Topics: Autoimmunity; BNT162 Vaccine; COVID-19; Fluorescein Angiography; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; SARS-CoV-2; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Vaccination | 2021 |
Outcomes of patients with acute Vogt-Koyanagi-Harada disease treated with intravenous corticosteroid pulse followed by the slow tapering of oral corticosteroid therapy.
Topics: Acute Disease; Adrenal Cortex Hormones; Glucocorticoids; Humans; Inflammation; Methylprednisolone; Middle Aged; Retrospective Studies; Uveomeningoencephalitic Syndrome | 2023 |
Successive onset of Vogt-Koyanagi-Harada syndrome in father and son.
Topics: Adult; Fathers; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Nuclear Family; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2023 |
A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
Topics: Child, Preschool; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Intraocular Pressure; Methylprednisolone; Ophthalmoscopy; Recurrence; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2019 |
Vogt-Koyanagi-Harada syndrome: importance of early treatment.
Topics: Adrenal Cortex Hormones; Adult; Cyclosporine; Female; Humans; Immunosuppressive Agents; Methylprednisolone; Uveomeningoencephalitic Syndrome | 2020 |
Serous Macular Detachment in Probable Vogt-Koyanagi-Harada Syndrome.
Topics: Administration, Oral; Blindness; Glucocorticoids; Headache; Humans; Infusions, Intravenous; Male; Methylprednisolone; Prednisone; Retinal Detachment; Subretinal Fluid; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2020 |
A case presentation of an IgA nephropathy patient with Vogt-Koyanagi-Harada syndrome.
Topics: Cyclophosphamide; Fluorescein Angiography; Glomerulonephritis, IGA; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Methylprednisolone; Middle Aged; Prednisone; Retina; Retinal Vessels; Uveomeningoencephalitic Syndrome | 2020 |
BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Topics: Acute Disease; Adult; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2021 |
The effect on choroidal changes of the route of systemic corticosteroids in acute Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Choroid; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2017 |
Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography.
Topics: Adolescent; Adult; Choroid; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Retina; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2019 |
A case of Vogt Koyanagi Harada disease in a 16 year old girl.
Topics: Adolescent; Anti-Inflammatory Agents; Blindness; Female; Humans; Methylprednisolone; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2017 |
Vogt-Koyanagi-Harada disease-like uveitis induced by vemurafenib for metastatic cutaneous malignant melanoma.
Topics: Angiography; Antineoplastic Agents; Female; Humans; Melanoma; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Retina; Skin Neoplasms; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome; Vemurafenib | 2018 |
Vogt-Koyanagi-Harada Disease Associated with Influenza A Virus Infection.
Topics: Acids, Carbocyclic; Adult; Antiviral Agents; Cyclopentanes; Glucocorticoids; Guanidines; Humans; Influenza A virus; Influenza, Human; Male; Methylprednisolone; Retinal Detachment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2018 |
Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Topics: Acute Disease; Adult; Aged; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Recurrence; Retrospective Studies; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2019 |
Vogt-Koyanagi-Harada syndrome presenting with bilateral optic disc swelling and leptomeningeal enhancement.
Topics: Administration, Intravenous; Aged; Diagnosis, Differential; Female; Fluorescein Angiography; Glucocorticoids; Humans; Magnetic Resonance Imaging; Meninges; Methylprednisolone; Papilledema; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2019 |
Teaching NeuroImages: A case of Vogt-Koyanagi-Harada disease with bilateral retinal detachment.
Topics: Adult; Glucocorticoids; Headache; Humans; Keratitis; Magnetic Resonance Imaging; Male; Methylprednisolone; Nausea; Paresthesia; Postural Balance; Retinal Detachment; Sensation Disorders; Tinnitus; Uveomeningoencephalitic Syndrome; Vision Disorders | 2019 |
Alopecia in a patient with Vogt-Koyanagi-Harada disease.
Topics: Alopecia; Female; Glucocorticoids; Humans; Methylprednisolone; Uveomeningoencephalitic Syndrome; Young Adult | 2014 |
Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Choroid Diseases; Cross-Sectional Studies; Dilatation, Pathologic; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Retinal Diseases; Retinal Pigment Epithelium; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2014 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antigens, CD20; Audiometry; Cyclosporine; Dexamethasone; Female; Hearing Loss; Hearing Loss, Sensorineural; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Panuveitis; Prednisolone; Prednisone; Prognosis; Recurrence; Remission Induction; Rituximab; Uveitis; Uveomeningoencephalitic Syndrome | 2015 |
High rate of clinical recurrence in patients with Vogt-Koyanagi-Harada disease treated with early high-dose corticosteroids.
Topics: Adolescent; Adult; Brazil; Child; Chronic Disease; Female; Fibrosis; Fluorescein Angiography; Glucocorticoids; HLA-DRB1 Chains; Humans; Male; Methylprednisolone; Middle Aged; Polymerase Chain Reaction; Prednisone; Prognosis; Pulse Therapy, Drug; Recurrence; Retina; Retrospective Studies; Uveomeningoencephalitic Syndrome; Young Adult | 2015 |
Vogt-Koyanagi-Harada disease in 3-year-old boy.
Topics: Child, Preschool; Glucocorticoids; Humans; Hyperemia; Infusions, Intravenous; Male; Methylprednisolone; Retinal Detachment; Tomography, Optical Coherence; Uveitis, Anterior; Uveomeningoencephalitic Syndrome; Visual Acuity | 2015 |
Vogt-Koyanagi-Harada disease after stapedotomy.
Topics: Choroiditis; Dexamethasone; Female; Fluorescein Angiography; Glucocorticoids; Hearing Loss, Bilateral; Humans; Infusions, Intravenous; Methylprednisolone; Middle Aged; Papilledema; Retinal Detachment; Stapes Surgery; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2015 |
RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Betamethasone; Biomarkers; Drug Combinations; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisolone; Retinal Detachment; Retinal Pigment Epithelium; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2016 |
Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids.
Topics: Adolescent; Adult; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Recovery of Function; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Young Adult | 2015 |
Vogt-Koyanagi-Harada Syndrome following influenza vaccination.
Topics: Female; Fluorescein Angiography; Glucocorticoids; Humans; Influenza Vaccines; Methylprednisolone; Middle Aged; Retinal Detachment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2016 |
Chronic Recurrent Vogt-Koyanagi-Harada Disease and Development of 'Sunset Glow Fundus' Predict Worse Retinal Sensitivity.
Topics: Administration, Oral; Adolescent; Adult; Child; Chronic Disease; Female; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Prognosis; Recurrence; Retina; Retinal Diseases; Retrospective Studies; Uveomeningoencephalitic Syndrome; Visual Acuity; Visual Field Tests; Visual Fields; Young Adult | 2017 |
Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Topics: Administration, Oral; Adult; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednisolone; Prednisolone; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2016 |
Fundus autofluorescence as a marker of disease severity in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adult; Biomarkers; Coloring Agents; Drug Combinations; Female; Fluorescein Angiography; Fundus Oculi; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Optical Imaging; Prednisone; Prospective Studies; Pulse Therapy, Drug; Retinal Pigment Epithelium; Severity of Illness Index; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Young Adult | 2016 |
Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fundus Oculi; Glucocorticoids; Humans; Inflammation; Injections, Intravenous; Male; Methylprednisolone; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Uveitis; Uveomeningoencephalitic Syndrome; Visual Acuity | 2017 |
Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Choroid; Choroid Diseases; Female; Fundus Oculi; Humans; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2017 |
Spectral-domain cirrus optical coherence tomography of choroidal striations seen in the acute stage of Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adult; Choroid Diseases; Fluorescein Angiography; Glucocorticoids; Humans; Imaging, Three-Dimensional; Infusions, Intravenous; Methylprednisolone; Pigment Epithelium of Eye; Prospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2009 |
[Vogt-Koyanagi-Harada syndrome].
Topics: Anti-Inflammatory Agents; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Uveomeningoencephalitic Syndrome; Vision Disorders; Visual Acuity; Vitiligo | 2009 |
Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adult; Anti-Inflammatory Agents; Choroid; Disease Progression; Female; Fluorescein Angiography; Fundus Oculi; Humans; Indocyanine Green; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisone; Switzerland; Time Factors; Tokyo; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2010 |
Vogt-Koyanagi-Harada disease associated with brainstem encephalitis.
Topics: Adult; Anti-Inflammatory Agents; Brain Stem; Encephalitis; Humans; Magnetic Resonance Imaging; Male; Methylprednisolone; Prednisolone; Uveomeningoencephalitic Syndrome | 2009 |
Treatment of Vogt-Koyanagi-Harada syndrome in pregnancy.
Topics: Adult; Female; Glucocorticoids; Humans; Infusions, Intravenous; Methylprednisolone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retinal Detachment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2009 |
Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Topics: Acute Disease; Adult; Aged; Cysts; Female; Fluorescein Angiography; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Retinal Detachment; Retinal Photoreceptor Cell Outer Segment; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2009 |
Mutton fat-like subretinal precipitates associated with Vogt-Koyanagi-Harada disease.
Topics: Female; Humans; Japan; Methylprednisolone; Middle Aged; Retinal Detachment; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2010 |
[Vogt-Koyanagi-Harada disease associated with interferon-alpha and ribavirin therapy for chronic hepatitis C infection].
Topics: Adrenal Cortex Hormones; Adult; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Male; Methylprednisolone; Recombinant Proteins; Ribavirin; Tropicamide; Uveomeningoencephalitic Syndrome | 2010 |
OCT interpretations.
Topics: Acute Disease; Cysts; Fluorescein Angiography; Glucocorticoids; Humans; Methylprednisolone; Prednisolone; Retinal Detachment; Retinal Photoreceptor Cell Outer Segment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2010 |
Intravitreal bevacizumab injection for persistent serous retinal detachment associated with Vogt-Koyanagi-Harada disease.
Topics: Adult; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Humans; Indocyanine Green; Intravitreal Injections; Methylprednisolone; Pulse Therapy, Drug; Retinal Detachment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Vascular Endothelial Growth Factor A; Visual Acuity | 2011 |
Auditory and vestibular manifestations of Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Child; Cochlear Implantation; Diagnosis, Differential; Female; Hearing Loss, Bilateral; Hearing Loss, Sensorineural; Humans; Male; Methylprednisolone; Middle Aged; Time Factors; Uveomeningoencephalitic Syndrome; Young Adult | 2011 |
Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Adult; Body Weights and Measures; Choroid; Female; Fluorescein Angiography; Fovea Centralis; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Retinal Detachment; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2011 |
Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anterior Chamber; Axial Length, Eye; Body Weights and Measures; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2010 |
Development of bullous retinal detachment during systemic corticosteroid treatment.
Topics: Administration, Oral; Central Serous Chorioretinopathy; Diagnostic Errors; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections, Intravenous; Methylprednisolone; Middle Aged; Prednisolone; Retinal Detachment; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome | 2011 |
Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography.
Topics: Acute Disease; Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Intravenous; Laser Coagulation; Male; Methylprednisolone; Middle Aged; Prednisolone; Retina; Retinal Diseases; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Young Adult | 2011 |
Vogt-Koyanagi-Harada syndrome: a rare but important differential diagnosis of viral meningitis.
Topics: Adolescent; Anti-Inflammatory Agents; Female; Humans; Meningitis, Viral; Methylprednisolone; Uveomeningoencephalitic Syndrome | 2012 |
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Topics: Acute Disease; Adult; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Glucocorticoids; Humans; Indocyanine Green; Male; Methylprednisolone; Middle Aged; Prednisolone; Recurrence; Retrospective Studies; Tomography, Optical Coherence; Uveomeningoencephalitic Syndrome; Visual Acuity | 2012 |
Neck stiffness and papilloedema due to Harada syndrome.
Topics: Adult; Female; Glucocorticoids; Humans; Methylprednisolone; Neck Pain; Papilledema; Uveomeningoencephalitic Syndrome | 2012 |
The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Child; Coloring Agents; Drug Therapy, Combination; Female; Fluorescein Angiography; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Indocyanine Green; Infusions, Intravenous; Male; Methylprednisolone; Mycophenolic Acid; Ophthalmoscopy; Prednisone; Prospective Studies; Secondary Prevention; Treatment Outcome; Uveitis, Posterior; Uveomeningoencephalitic Syndrome; Visual Acuity; Young Adult | 2012 |
[Disc neovascularization in a patient with Vogt-Koyanagi-Harada disease and efficacy of steroid pulse therapy].
Topics: Adult; Female; Humans; Methylprednisolone; Neovascularization, Pathologic; Optic Disk; Pulse Therapy, Drug; Uveomeningoencephalitic Syndrome | 2006 |
Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Child; Female; Glucocorticoids; Humans; Injections, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisone; Retrospective Studies; Treatment Outcome; Uveomeningoencephalitic Syndrome; Visual Acuity | 2006 |
Vogt-Koyanagi-Harada's disease presenting polymorphonuclear pleocytosis in the cerebrospinal fluid at the early active stage.
Topics: Adolescent; Diagnosis, Differential; Female; Fundus Oculi; Glucocorticoids; Humans; Leukocytosis; Meningoencephalitis; Methylprednisolone; Pulse Therapy, Drug; Uveitis; Uveomeningoencephalitic Syndrome | 2006 |
Vogt-Koyanagi-Harada disease and polymorphonuclear leuokocyts pleocytosis in cerebrospinal fluid.
Topics: Anti-Inflammatory Agents; Glucose; Humans; Leukocytosis; Meningoencephalitis; Methylprednisolone; Neutrophils; Uveitis; Uveomeningoencephalitic Syndrome | 2006 |
Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Diagnosis, Differential; Dose-Response Relationship, Drug; Exudates and Transudates; Female; Fluorescein; Fluorescein Angiography; Fluorescent Dyes; Follow-Up Studies; Fundus Oculi; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisolone; Retina; Retinal Detachment; Retrospective Studies; Severity of Illness Index; Tomography, Optical Coherence; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2007 |
VOGT-KOYANAGI DISEASE.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methylprednisolone; Methylprednisolone Acetate; Prednisolone; Uveomeningoencephalitic Syndrome; Visual Acuity | 1962 |
Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
Topics: Administration, Oral; Child, Preschool; Female; Fundus Oculi; Humans; Infusions, Intravenous; Meningitis, Aseptic; Methylprednisolone; Neurologic Examination; Prednisolone; Retinal Detachment; Uveomeningoencephalitic Syndrome; Visual Acuity | 1995 |
Intravenous methylprednisolone for aseptic meningitis in Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Female; Humans; Injections, Intravenous; Meningitis, Aseptic; Methylprednisolone; Treatment Outcome; Uveomeningoencephalitic Syndrome | 2000 |
Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis.
Topics: Adult; Cyclosporine; Cytoplasmic Granules; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Macrophages; Melanins; Meningitis, Aseptic; Meningoencephalitis; Methylprednisolone; Recurrence; Uveomeningoencephalitic Syndrome | 2000 |
The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Child; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Fluorescent Dyes; Glucocorticoids; Humans; Indocyanine Green; Male; Methylprednisolone; Middle Aged; Prospective Studies; Retrospective Studies; Uveomeningoencephalitic Syndrome | 2001 |
Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Anterior Chamber; Betamethasone; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Inflammation; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Prednisolone; Uveomeningoencephalitic Syndrome; Visual Acuity | 1990 |